Neural Control of Myocardial Excitability at the Nerve Myocyte Interface

神经肌细胞界面心肌兴奋性的神经控制

基本信息

项目摘要

ABSTRACT – Project 1 Sudden cardiac death due to ventricular arrhythmias and heart failure are the leading causes morbidity and mortality in the United States. The autonomic nervous system plays a major role in the pathophysiology of arrhythmias and heart failure. Neuraxial modulation represents an important avenue for therapeutic intervention. However, the structural and functional determinants of the release of neurotransmitters and peptides in the myocardium in health and disease, which effectively govern cardiac excitability and mechanical function, as well as propensity toward arrhythmias, remain largely unknown. Myocardial scars seen in ischemic and nonischemic cardiomyopathy show abnormal innervation and nerve sprouting at the border zone of scars due to neural remodeling, which have been implicated in the pathophysiology of ventricular arrhythmias. We propose to test “The Spatiotemporal Heterogeneity of Neurotransmitter Release Hypothesis’ – which postulates that scars alter the ultrastructure of nerves and cause non-uniform reflex-mediated neurotransmitter release in the myocardium and represents a crucial/proximate cause of lethal arrhythmias. The major goal of this project is to investigate the structural (myocardial) and functional (neural) changes in the heart that occur because of heart disease and subsequently lead to ventricular arrhythmias. In aims 1 and 2, we will determine the ultrastructure and define the nerve-myocyte stoichiometry and release profiles of neurotransmitters and peptides in normal and diseased hearts in response to physiological stressors and specifically define areas of non-uniform release of neurotransmitters. In aim 3, we will determine the underlying mechanism and potential benefit of vagal nerve stimulation in mitigating the pathological remodeling related to scar formation and autonomic innervation. Regional structural and functional changes in innervation of scar and border zone regions will be studied using high density electrophysiological mapping and real time neurotransmitter and neuropeptide measurements which will be correlated with structural changes at the border zones of infarcts using tissue clearing techniques in a relevant large animal model and in human hearts. Understanding the underlying myocardial and neural mechanisms leading to arrhythmias has the potential to develop and precisely target therapies that inspire therapies for the prevention of sudden cardiac death and progression of heart failure.
摘要-项目1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KALYANAM SHIVKUMAR其他文献

KALYANAM SHIVKUMAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KALYANAM SHIVKUMAR', 18)}}的其他基金

Cardiac Neuromodulation: Mechanisms and Therapeutics
心脏神经调节:机制和治疗
  • 批准号:
    10627573
  • 财政年份:
    2023
  • 资助金额:
    $ 49.29万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10627574
  • 财政年份:
    2023
  • 资助金额:
    $ 49.29万
  • 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
  • 批准号:
    10428718
  • 财政年份:
    2019
  • 资助金额:
    $ 49.29万
  • 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
  • 批准号:
    9808011
  • 财政年份:
    2019
  • 资助金额:
    $ 49.29万
  • 项目类别:
CARDIAC NEUROMODULATION IN HUMANS: MECHANISMS & THERAPIES
人类心脏神经调节:机制
  • 批准号:
    10190645
  • 财政年份:
    2019
  • 资助金额:
    $ 49.29万
  • 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
  • 批准号:
    7078849
  • 财政年份:
    2006
  • 资助金额:
    $ 49.29万
  • 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
  • 批准号:
    7417817
  • 财政年份:
    2006
  • 资助金额:
    $ 49.29万
  • 项目类别:
ELECTROPHYSIOLOGICAL EFFECTS OF NEURAL REMODELING OF THE VENTRICLES
心室神经重塑的电生理效应
  • 批准号:
    8458497
  • 财政年份:
    2006
  • 资助金额:
    $ 49.29万
  • 项目类别:
ELECTROPHYSIOLOGICAL EFFECTS OF NEURAL REMODELING OF THE VENTRICLES
心室神经重塑的电生理效应
  • 批准号:
    8603270
  • 财政年份:
    2006
  • 资助金额:
    $ 49.29万
  • 项目类别:
Electrophysiological Effects of Neural Remodeling of the Ventricles
心室神经重塑的电生理效应
  • 批准号:
    7616206
  • 财政年份:
    2006
  • 资助金额:
    $ 49.29万
  • 项目类别:

相似海外基金

EFFECTS OF BETA ADRENERGIC ANTAGONISTS
β 肾上腺素能拮抗剂的作用
  • 批准号:
    6248122
  • 财政年份:
    1997
  • 资助金额:
    $ 49.29万
  • 项目类别:
GLAUCOMA AND ALPHA ADRENERGIC ANTAGONISTS
青光眼和α肾上腺素能拮抗剂
  • 批准号:
    3261472
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
SELECTIVE ADRENERGIC ANTAGONISTS & INTRAOCULAR PRESSURE
选择性肾上腺素能拮抗剂
  • 批准号:
    3038642
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
GLAUCOMA AND ALPHA ADRENERGIC ANTAGONISTS
青光眼和α肾上腺素能拮抗剂
  • 批准号:
    3261474
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
GLAUCOMA AND ALPHA ADRENERGIC ANTAGONISTS
青光眼和α肾上腺素能拮抗剂
  • 批准号:
    3261475
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
GLAUCOMA AND ALPHA ADRENERGIC ANTAGONISTS
青光眼和α肾上腺素能拮抗剂
  • 批准号:
    3261473
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
GLAUCOMA AND ALPHA ADRENERGIC ANTAGONISTS
青光眼和α肾上腺素能拮抗剂
  • 批准号:
    3261476
  • 财政年份:
    1985
  • 资助金额:
    $ 49.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了